Oncology Cardiology / Cardiovascular Respiratory / COPD / Asthma Infectious Disease Gastroenterology Diabetes / Metabolic Neurology Rheumatology Women's Health Mental Health / Psychiatry Dermatology Rare Diseases Men's Health
Clinical Trial ● Currently Recruiting NCT07347431

Large Language Model for Understanding and Monitoring Elderly Neurocognition

Large Language Model for Understanding and Monitoring Elderly Neurocognition — Recruiting • Neurology • NCT07347431.

📅 21 Apr 2026 ⏱ 2 min read
Currently Recruiting
This trial is actively seeking participants in the UK. Discuss eligibility with your patient before referring.
Status
Currently Recruiting
NCT ID
NCT07347431
Sponsor
Northumbria Healthcare NHS Foundation Trust
Start
2026-03-19
ClinicaliQ Trial Snapshot
  • Large Language Model for Understanding and Monitoring Elderly Neurocognition — Recruiting • Neurology • NCT07347431.
  • What is being tested: A large language model (AI system) designed to analyse collateral histories from family members and caregivers to help understand and monitor cognitive changes in elderly patients, potentially improving dementia detection.
  • Patient eligibility overview: Elderly patients with suspected or established cognitive decline, alongside their family members or caregivers who can provide detailed accounts of observed changes in memory and thinking abilities.
Use This Page For
  • Quick orientation before opening the registry record.
  • Checking recruitment status, phase and sponsor at a glance.
  • Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying

Dementia affects millions of people worldwide, and early diagnosis is essential for getting the right care and support. Doctors rely on collateral histories (accounts from family members or caregivers) to understand changes in a person's memory and thinking. However, these histories can be incomplete, unstructured, or difficult to obtain, making diagnosis more challenging. This study will test LUMEN (Large Language Model for Understanding and Monitoring Elderly Neurocognition), an AI-powered conversation tool designed to help caregivers describe their loved one's symptoms more effectively. By asking structured questions and guiding the conversation,…

Eligibility Snapshot
  • Carers of patients attending Memory Clinic appointments; Aged 18 or over; Both patients and cares can provide informed consent; Basic English literacy Clinicians must have at least 2 years of specialist dementia care experience and be personally responsible for dementia diagnosis; Must be provide informed consent

Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.

Full Trial Details
View this trial on the source registry
Eligibility criteria, protocol, and results when available
View Trial ↗
Share: Twitter/X LinkedIn
Related

Related Clinical Intelligence

Guidelines, Drug Science, safety briefs and education connected to this trial area.

Clinical Brief
Families hit by long waits for dementia diagnosis
Neurology · BBC Health · 02 Sep 2026
Dementia diagnosis delays are widespread, with patients experiencing waits of months to years, creating prolonged uncertainty for families during a critical period…
View brief →
Clinical Brief
My daughter has childhood dementia and may not live past 16
Neurology · BBC Health · 01 Apr 2026
Key Clinical Takeaways Childhood dementia represents a group of rare progressive neurodegenerative disorders with devastating outcomes—Sophia's case illustrates the severe functional decline…
View brief →
Clinical Brief
AI may speed up search for drugs to treat brain conditions
Neurology · BBC Health · 22 May 2026
AI tools are being developed to accelerate drug discovery for neurological conditions including motor neurone disease, potentially reducing development timelines This approach…
View brief →
Clinical Brief
Anaemia and the new dementia link
Neurology · BBC Health · 07 May 2026
Key Takeaways for Clinical Practice Anaemia has been identified as a newly recognised risk factor for dementia, suggesting haemoglobin levels should be…
View brief →
Clinical Brief
‘My son can now enjoy life’: Children with severe form of epilepsy helped by new drug
Neurology · BBC Health · 04 Mar 2026
Fenfluramine has demonstrated clinical benefit in children with Dravet syndrome, a severe and treatment-resistant form of early-onset epilepsy, with families reporting significant…
View brief →
Guideline
Dementia: Assessment, Management and Support (NICE NG97)
Neurology · 25 Mar 2026
Use cognitive testing (MMSE or MoCA) combined with appropriate imaging to confirm dementia diagnosis • Prescribe acetylcholinesterase inhibitors (donepezil, rivastigmine, or galantamine)…
View guideline →